Share Email Print
cover

Proceedings Paper • new

Diagnostics of high grade cervical intraepithelial neoplasia with Mueller matrix polarimetry
Author(s): M. Kupinski; M. Boffety; R. Ossikovski; A. Pierangelo; J. Rehbinder; J. Vizet; F. Goudail; T. Novikova
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

An enhancement of contrast between healthy and neoplastic zones in Mueller matrix images of excised cervical tissue was demonstrated in our prior work for the visible wavelength range. In this paper we present the statistical analysis of Mueller polarimetric data for the diagnostics of high grade cervical intraepithelial neoplasia. The results of linear and non-linear post-processing compressions of the full Mueller matrix are discussed and compared in terms of diagnostic performance. The final goal of these studies is to estimate and compare the diagnostic usefulness of 16 polarimetric measurements required for the reconstruction of complete Mueller matrix of a sample, while looking for an optimal design of future imaging protocols.

Paper Details

Date Published: 22 July 2019
PDF: 3 pages
Proc. SPIE 11075, Novel Biophotonics Techniques and Applications V, 1107509 (22 July 2019); doi: 10.1117/12.2527117
Show Author Affiliations
M. Kupinski, LIPCM, CNRS, École Polytechnique, Univ. Paris Saclay (France)
College of Optical Sciences, The Univ. of Arizona (United States)
M. Boffety, Institut d'Optique Graduate School (France)
R. Ossikovski, LIPCM, CNRS, École Polytechnique, Univ. Paris Saclay (France)
A. Pierangelo, LIPCM, CNRS, École Polytechnique, Univ. Paris Saclay (France)
J. Rehbinder, LIPCM, CNRS, École Polytechnique, Univ. Paris Saclay (France)
J. Vizet, LIPCM, CNRS, École Polytechnique, Univ. Paris Saclay (France)
F. Goudail, Institut d'Optique Graduate School (France)
T. Novikova, LIPCM, CNRS, École Polytechnique, Univ. Paris Saclay (France)


Published in SPIE Proceedings Vol. 11075:
Novel Biophotonics Techniques and Applications V
Arjen Amelink; Seemantini K. Nadkarni, Editor(s)

© SPIE. Terms of Use
Back to Top